About Serenity

U.S. FDA Approves Serenity Pharmaceutical’s Noctiva™ (desmopressin acetate) – the First Drug Approved for the Treatment of Nocturia

Founded in 2007 and located in Milford, Pennsylvania, Serenity Pharmaceuticals is focused on developing products that address urinary conditions that impact the health and well-being of millions of people. Serenity Pharmaceuticals is working to develop patented pharmaceuticals with unique delivery mechanisms and formulations, to provide safe and effective treatments for voiding disorders.